Columbus Circle Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-296,991
Closed -$38.5M 171
2019
Q1
$38.5M Buy
296,991
+19,974
+7% +$2.43M 0.98% 40
2018
Q4
$32.1M Buy
277,017
+80,396
+41% +$8.98M 0.91% 42
2018
Q3
$21.1M Buy
+196,621
New +$19.7M 0.42% 93
2017
Q1
Sell
-38,306
Closed -$2.82M 296
2016
Q4
$2.82M Sell
38,306
-1,295,516
-97% -$96.5M 0.04% 209
2016
Q3
$107M Buy
1,333,822
+92,143
+7% +$7.38M 1.16% 25
2016
Q2
$97.8M Sell
1,241,679
-299,929
-19% -$22.6M 0.98% 26
2016
Q1
$111M Sell
1,541,608
-53,659
-3% -$4.06M 0.99% 31
2015
Q4
$134M Buy
1,595,267
+347,835
+28% +$28.9M 1.08% 28
2015
Q3
$104M Buy
1,247,432
+984,047
+374% +$83.1M 0.85% 35
2015
Q2
$22M Buy
+263,385
New +$20.1M 0.16% 160

Other funds holding LLY

Columbus Circle Investors's LLY Position: Q2 2019 in Review

Columbus Circle Investors sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 296,991 shares — an estimated $38.5M sold.

Columbus Circle Investors first reported a position in LLY in Q2 2015 and held it in 10 quarters. The position peaked at $134M in Q4 2015. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Columbus Circle Investors reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 296,991 Eli Lilly shares in Q2 2019, an estimated $38.5M.
  • Columbus Circle Investors first reported a position in Eli Lilly in Q2 2015 and held it in 10 quarters.
  • Columbus Circle Investors's Eli Lilly position peaked at $134M in Q4 2015.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Columbus Circle Investors's 13F filing for Q2 2019, filed 2 Aug 2019.